Tiziana Life Sciences to Present at BTIG’s Virtual Biotechnology Conference

    NEXT STORY
    Kymab Announces Positive Phase 2a Results for KY1005 in Moderate to Severe Atopic Dermatitis
    PREV STORY
    Basilea reports strong financial results for half-year 2020, progress in R&D portfolio and successful completion of strategic projects, despite COVID-19
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Orphan Drugs Market to touch US$318.5 billion by 2025 – TMR

    author_avatar
    NASDAQ Market News

    Teleflex Wins New Zealand Innovation Award for UroLift System for Patients with Enlarged Prostate

    author_avatar
    NASDAQ Market News

    Coherus BioSciences Appoints Samuel Nussbaum, M.D. to Board of Directors

    REDWOOD CITY, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today ...

    author_avatar
    NASDAQ Market News